69 Small molecule Plasmodium FKBP35 inhibitor as a potential antimalaria agent.
http://www.nature.com/srep/2013/130826/srep02501/full/srep02501.html
68 A Microscale Human Liver Platform that Supports the Hepatic Stages of Plasmodium falciparum and vivax.
http://www.cell.com/cell-host-microbe/abstract/S1931-3128(13)00221-7
67 Leishmania Evades Host Immunity by Inhibiting Antigen Cross-Presentation through Direct Cleavage of the SNARE VAMP8.
http://www.cell.com/cell-host-microbe/abstract/S1931-3128(13)00219-9
66 Apoptosis and dysfunction of blood dendritic cells in patients with falciparum and vivax malaria.
http://jem.rupress.org/content/210/8/1635.abstract
65 Disrupting malaria parasite AMA1–RON2 interaction with a small molecule prevents erythrocyte invasion.
http://www.nature.com/ncomms/2013/130802/ncomms3261/full/ncomms3261.html
64 Torins are potent antimalarials that block replenishment of Plasmodium liver stage parasitophorous vacuole membrane proteins.
http://www.pnas.org/content/110/30/E2838.abstract
63 The malaria parasite Plasmodium falciparum escapes immune detection by expressing one of 60 antigenically distinct var genes at any one time during the course of infection: here it is shown that the P. falciparum protein PfSETvs has a key role in var gene silencing through the trimethylation of histone H3K36.
http://www.nature.com/nature/journal/v499/n7457/full/nature12361.html
62 Chemical and genetic validation of thiamine utilization as an antimalarial drug target.
http://www.nature.com/ncomms/2013/130627/ncomms3060/full/ncomms3060.html
61 Severe malaria is associated with parasite binding to endothelial protein C receptor.
http://www.nature.com/nature/journal/v498/n7455/full/nature12216.html
60 Wolbachia uses a host microRNA to regulate transcripts of a methyltransferase, contributing to dengue virus inhibition in Aedes aegypti.
http://www.pnas.org/content/110/25/10276.abstract
|
